Oncology

Oncology has emerged as one of the most sought-after targets in physician practice management (PPM) M&A. Driven by oncology’s favorable reimbursement profile, the capital-intensive nature of modern cancer care, and private equity’s sustained appetite for durable, recurring clinical revenue, valuations for oncology platforms have reached levels that were inconceivable a decade ago. Yet the market […]

Oncology is simultaneously one of healthcare’s greatest success stories and one of its biggest financial challenges. Cancer care continues to benefit from breakthroughs in precision medicine and early detection, even as oncology spending is projected to approach $200 billion by 2029. At the same time, cancer programs are facing rising patient volumes, growing demand for

Remarkable scientific progress against cancer has changed very little for millions of patients globally, who face devastating physical, emotional and financial consequences after diagnosis, a new World Health Organization report has warned. One person in five will develop cancer, according to WHO estimates, and the disease will touch 92% of people, either through their own

Cancer death rates in the U.S. have dropped dramatically in the past 35 years, falling by 35%, according to a report from the American Association for Cancer Research. The decline, which translates to nearly 5 million fewer cancer deaths since 1991, has been driven in large part by increased screening and advances in cancer treatments.